YY1
Transcriptional repressor protein YY1
Also known as: DELTA, INO80S, NF-E1, TYY1_HUMAN, UCRBP, YIN-YANG-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P25490
- Gene
- YY1
- Ensembl
- ENSG00000100811
- Chromosome
- 14
- Canonical length
- 414 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies
OverviewNCBI Gene
YY1 is a ubiquitously distributed transcription factor belonging to the GLI-Kruppel class of zinc finger proteins. The protein is involved in repressing and activating a diverse number of promoters. YY1 may direct histone deacetylases and histone acetyltransferases to a promoter in order to activate or repress the promoter, thus implicating histone modification in the function of YY1. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
414 residues, UniProt reviewed canonical sequence.
>P25490|YY1
1 MASGDTLYIA TDGSEMPAEI VELHEIEVET IPVETIETTV VGEEEEEDDD DEDGGGGDHG
61 GGGGHGHAGH HHHHHHHHHH PPMIALQPLV TDDPTQVHHH QEVILVQTRE EVVGGDDSDG
121 LRAEDGFEDQ ILIPVPAPAG GDDDYIEQTL VTVAAAGKSG GGGSSSSGGG RVKKGGGKKS
181 GKKSYLSGGA GAAGGGGADP GNKKWEQKQV QIKTLEGEFS VTMWSSDEKK DIDHETVVEE
241 QIIGENSPPD YSEYMTGKKL PPGGIPGIDL SDPKQLAEFA RMKPRKIKED DAPRTIACPH
301 KGCTKMFRDN SAMRKHLHTH GPRVHVCAEC GKAFVESSKL KRHQLVHTGE KPFQCTFEGC
361 GKRFSLDFNL RTHVRIHTGD RPYVCPFDGC NKKFAQSTNL KSHILTHAKA KNNQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against YY1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 62 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 62 nTPM
- thymus: 59 nTPM
- liver: 55 nTPM
- tonsil: 45 nTPM
- thyroid gland: 42 nTPM
- placenta: 41 nTPM
Single-cell type
- basal keratinocytes: 259 nCPM
- neutrophils: 245 nCPM
- esophageal apical cells: 239 nCPM
- erythrocyte progenitors: 237 nCPM
- suprabasal keratinocytes: 234 nCPM
- syncytiotrophoblasts: 225 nCPM
Immune cell
- eosinophil: 12 nTPM
- neutrophil: 11 nTPM
- NK-cell: 9.6 nTPM
- naive B-cell: 8.3 nTPM
- T-reg: 8.3 nTPM
- memory CD8 T-cell: 5.9 nTPM
Brain region
- cerebellum: 54 nTPM
- white matter: 50 nTPM
- cerebral cortex: 47 nTPM
- hippocampal formation: 44 nTPM
- thalamus: 42 nTPM
- basal ganglia: 41 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about YY1.
Disease | AllUniProt
Conditions YY1 is implicated in, by any mechanism.
- Gabriele-de Vries syndrome (GADEVS) MIM:617557
Disease | GeneticClinVar
47 pathogenic / likely-pathogenic of 160 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.2
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 3.31
- DepMap mean gene effect
- -0.76
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anterior/posterior pattern specification
- B cell differentiation
- camera-type eye morphogenesis
- cellular response to interleukin-1
- cellular response to UV
- chromatin remodeling
- DNA damage response
- double-strand break repair via homologous recombination
- immunoglobulin heavy chain V-D-J recombination
- negative regulation of cell growth involved in cardiac muscle cell development
- negative regulation of gene expression
- negative regulation of interferon-beta production
- negative regulation of miRNA transcription
- negative regulation of transcription by RNA polymerase II
- positive regulation of DNA repair
- positive regulation of DNA-templated transcription
- positive regulation of gene expression
- positive regulation of telomere maintenance in response to DNA damage
- positive regulation of transcription by RNA polymerase II
- regulation of cell cycle
- regulation of chromosome organization
- regulation of DNA repair
- regulation of DNA replication
- regulation of DNA strand elongation
- regulation of embryonic development
- regulation of transcription by RNA polymerase II
- response to prostaglandin F
- response to UV-C
- RNA localization
- spermatogenesis
- telomere maintenance
Molecular functions
- chromatin binding
- cis-regulatory region sequence-specific DNA binding
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription factor binding
- DNA-binding transcription repressor activity
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- four-way junction DNA binding
- RNA binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- SMAD binding
- transcription cis-regulatory region binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of YY1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads YY1 as an antibody target. Whether an autoantibody or antibody against YY1 could matter depends on whether native YY1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
YY1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label YY1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...